- Glenmark Pharma to develop GRC 15300 - Trading Markets (press release)
- Suven to raise funds for phase II trials of Alzheimer’s molecule - Economic Times
- Glenmark molecule gets USFDA nod - Sify
- Ranbaxy close to completing trials for new malaria drug - Hindu Business Line
- Piramal Life's diabetes drug enters clinical trials - Reuters India
Glenmark diabetes drug to enter phase III trials by 2009-end - Reuters India
Glenmark diabetes drug to enter phase III trials by 2009-endReuters India, IndiaMUMBAI (Reuters) - Glenmark Pharmaceuticals Ltd said on Wednesday its experimental new molecule for the treatment of diabetes, Melogliptin, is likely to start final stage global clinical trials by end-2009. Melogliptin has completed phase IIb, ...novel molecule for Diabetes, Melogliptin to enter phase III trials PipelineReview.com (press release)Glenmark's Novel Molecule for Diabetes, Melogliptin to Enter Phase ... SunHerald.com (press release)all 19 news articles
